Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1045 results for "aurobindo"

Buy Aurobindo Pharma, BPCL: Meghana Malkan

Meghana Malkan of recommends buying Aurobindo Pharma and Bharat Petroleum Corporation. Money Control, 1 day ago
Buy Aurobindo Pharma, Lupin: Vishal Malkan Money Control, 4 weeks ago

128 images for aurobindo

India Infoline, 6 days ago
Money Today, 1 week ago
NDTV Profit, 6 days ago
NDTV Profit, 1 week ago
Business Standard, 1 week ago, 1 week ago
The Freepress Journal, 1 week ago
Money Control, 1 week ago, 5 days ago
Business Standard, 6 days ago
India Infoline

Your Stock Portfolio: Aurobindo Pharma on a healthy trend

Aurobindo Pharma on a healthy trend Here are answers to readers queries on the performance of their stock holdings. I bought Arobindo Pharma bought at ₹1,125. Should I hold? BP Kohli Aurobindo Pharma (₹1,431.8): The stock of Aurobindo ...
 Hindu Business Line2 days ago Aurobindo Pharma gets going on the US generic approval front  HT Syndication4 days ago Aurobindo at new high; Citi says top pick, target Rs 1945  Money Control6 days ago Pharma shares in focus; Aurobindo Pharma hits new high  Business Standard India6 days ago


Raj Vidya Kender: Discourse, Inner Peace, Ardra Hall, Huzur Road, 6pm. Sri Aurobindo Devotees Trust: Prayers to Sri Annai, Sasibalika Vidya Mandir, Azad Road, R.S. Puram, 10am.; Sri Annai Meditation Centre, W7C, Kovaipudur, 4pm. Jamaat-e-Islami ...
 The Hindu2 days ago

Buy Aurobindo Pharma with a target of Rs 1,505: Sandeep Wagle

'Aurobindo Pharma Ltd. is a 'BUY' call with a target of Rs 1,505 and a stop loss of Rs 1,410'
 Economic Times6 days ago Sell Aurobindo Pharma with a target of Rs 1,230: Mitesh Thacker  Economic Times2 weeks ago Buy Aurobindo Pharma; target of Rs 1654: Angel Broking  Money Control2 weeks ago Nifty likely to test 7,830 in 2-3 trading sessions: Mitesh Thacker  Economic Times2 weeks ago

Aurobindo Pharma may head higher: Sudarshan Sukhani

Sudarshan Sukhani of is of the view that Aurobindo Pharma may head higher.
 Money Control6 days ago Stay invested in Aurobindo Pharma: Sudarshan Sukhani  Money Control2 months ago Buy Aurobindo Pharma, advises Sudarshan Sukhani  Money Control2 months ago Buy Aurobindo Pharma, says Manish Hathiramani  Money Control2 months ago

Aurobindo Pharma scales record high

on BSE, with the stock extending recent gains. Meanwhile, the S BSE Sensex was down 130.40 points or 0.47% at 27,673.97 On BSE, so far 2.26 lakh shares were traded in the counter as against average daily volume of 1.35 lakh shares in the past one quarter. The ...
 Business Standard6 days ago Plethico Pharma gains 23.64% in two days after reaching settlement with Aurobindo  Business Standard2 months ago
NDTV Profit

Aurobindo Pharma Surges Over 4%, Hits 52-Week High

More From Market Aurobindo Pharma shares surged over 4 per cent to hit 52-week high of Rs 1,454 on the National Stock Exchange. Including today's gain the stock has surged around 14 per cent in last seven trading sessions after the company said ...
 NDTV Profit6 days ago Aurobindo @ 52-wk high; to raise Rs 2,165 cr via QIB  Economic Times2 months ago Aurobindo Pharma hits 52-week high  India Infoline2 months ago Aurobindo Pharma hits 52-week high on CCEA nod to raise capital via QIB  Economic Times2 months ago

The burger of old Delhi

Wimpy in Aurobindo Market offers five types of lamb burgers Until October 13 1996, when the golden arches were first seen in the city in Basant Lok Market, we Delhiites were MacDonald virgins. You can still make a return journey to your former ...
 Livemint.com5 days ago

Partho to face 2nd round of questioning at Pavlov Institute

In a bid to reconstruct the circumstances of the suicide of Aurobindo De in his Robinson Street house, police are trying to put together an idea of his activities of the last two days before conducting a second round of questioning of his son Partho ...
 The Statesman1 week ago

Aurobindo Pharma gains after securing USFDA approval for two generic drugs

Aurobindo Pharma rose 0.89% to Rs 1,371 at 13:53 IST on BSE after the company got final approvals from the USFDA to manufacture and market Azithromycin for injection USP, 500 mg/vial. The announcement was made during market hours today, 22 June 2015.
 Business Standard1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - aurobindo
Get updated on latest news & your favorite topics right in your inbox!
More     Less